This statistic shows the top promising pipeline drugs globally for chronic hepatitis B in 2014 , by peak year sales. The peak year sales of GS-9620 (Gilead Science) drug for chronic hepatitis B was almost 385 million US dollars in the year 2014.
Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GlobalData. (January 1, 2016). Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars) [Graph]. In Statista. Retrieved December 24, 2024, from https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData. "Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars)." Chart. January 1, 2016. Statista. Accessed December 24, 2024. https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData. (2016). Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 24, 2024. https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData. "Top Promising Pipeline Drugs for Chronic Hepatitis B as of End-2014, by Peak Year Sales (in Million U.S. Dollars)." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData, Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars) Statista, https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/ (last visited December 24, 2024)
Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars) [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
